Redefining Precision Molecular Diagnostics
DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world.
Less than 0.01% sensitivity on difficult or diminished samples
Rapid Results for Faster Diagnosis
First-time results on any sample size in less than two hours
The first and only
GMP-compliant facility with CA CLIA certification